122 related articles for article (PubMed ID: 37548052)
1. A semimechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase-based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukaemia.
Yin Q; Cheng Z; Yang M; Wang S; Xie F
Br J Clin Pharmacol; 2023 Dec; 89(12):3637-3647. PubMed ID: 37548052
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic study of delayed methotrexate excretion in children with acute lymphoblastic leukemia
.
Zang YN; Wang SZ; Qin Y; Zhang JR; Zhao LB; Wang XL
Int J Clin Pharmacol Ther; 2019 Aug; 57(8):402-407. PubMed ID: 31232278
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic study of methotrexate in children with acute lymphoblastic leukemia.
Zhang C; Zhai S; Yang L; Wu H; Zhang J; Ke X
Int J Clin Pharmacol Ther; 2010 Jan; 48(1):11-21. PubMed ID: 20040335
[TBL] [Abstract][Full Text] [Related]
4. Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma.
Wang SF; Huang KW; Chou YC; Lee HC; Wu PK; Chen WM; Hung GY; Chang YL
Cancer Med; 2023 Jun; 12(11):12354-12364. PubMed ID: 37062070
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia.
Medellin-Garibay SE; Hernández-Villa N; Correa-González LC; Morales-Barragán MN; Valero-Rivera KP; Reséndiz-Galván JE; Ortiz-Zamudio JJ; Milán-Segovia RDC; Romano-Moreno S
Cancer Chemother Pharmacol; 2020 Jan; 85(1):21-31. PubMed ID: 31673826
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia.
Gao X; Qian XW; Zhu XH; Yu Y; Miao H; Meng JH; Jiang JY; Wang HS; Zhai XW
Front Pharmacol; 2021; 12():701452. PubMed ID: 34326772
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of methotrexate in paediatric patients with acute lymphoblastic leukaemia and malignant lymphoma.
Zhan M; Sun Y; Zhou F; Wang H; Chen Z; Yan L; Li X
Xenobiotica; 2022 Mar; 52(3):265-273. PubMed ID: 35446233
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
[TBL] [Abstract][Full Text] [Related]
9. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.
Elbarbary NS; Ismail EA; Farahat RK; El-Hamamsy M
Nutrition; 2016 Jan; 32(1):41-7. PubMed ID: 26421385
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats.
Akbulut S; Elbe H; Eris C; Dogan Z; Toprak G; Otan E; Erdemli E; Turkoz Y
World J Gastroenterol; 2014 Aug; 20(29):10158-65. PubMed ID: 25110444
[TBL] [Abstract][Full Text] [Related]
12. Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia.
Schmiegelow K; Ifversen M
Pediatr Hematol Oncol; 1996; 13(5):433-41. PubMed ID: 10897815
[TBL] [Abstract][Full Text] [Related]
13. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
Choi SR; Park JW; Lee EB; Park JK
Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia.
Halonen P; Mattila J; Mäkipernaa A; Ruuska T; Schmiegelow K
Pediatr Blood Cancer; 2006 Jun; 46(7):762-6. PubMed ID: 16395677
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacogenetics of high-dose methotrexate in Chinese adult patients with non-Hodgkin lymphoma: a population analysis.
Yang L; Wu H; de Winter BCM; Sheng CC; Qiu HQ; Cheng Y; Chen J; Zhao QL; Huang J; Jiao Z; Xie RX
Cancer Chemother Pharmacol; 2020 May; 85(5):881-897. PubMed ID: 32246190
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
Yassin NA; Haroon M; Elhamshary A
Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine, methionine and S-adenosylhomocysteine levels following high-dose methotrexate treatment in pediatric patients with acute lymphoblastic leukemia or Burkitt lymphoma: association with hepatotoxicity.
Kubota M; Nakata R; Adachi S; Watanabe K; Heike T; Takeshita Y; Shima M
Leuk Lymphoma; 2014 Jul; 55(7):1591-5. PubMed ID: 24090503
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation.
Dalaklioglu S; Genc GE; Aksoy NH; Akcit F; Gumuslu S
Hum Exp Toxicol; 2013 Jun; 32(6):662-71. PubMed ID: 23424212
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
[TBL] [Abstract][Full Text] [Related]
20. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
Plard C; Bressolle F; Fakhoury M; Zhang D; Yacouben K; Rieutord A; Jacqz-Aigrain E
Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
